(Boursier.com) — In the 1st half, the turnover of Safe amounts to 2.76 million euros (including other income from activity of +15 kE and post IFRS15 impact of -80 kE). Up +31%, it is driven by double-digit growth: 27% for Safe Orthopedics and 38% for Safe medical.
Current operating income restated for depreciation, provisions and other income and expenses (=EBITDA) is in the 1st half of 2022, equal to -2.78 ME), an improvement of 25% compared to the 1st half of 2021 when it was -3.71 ME.
The net result is a loss of -3.89 ME as of June 30, 2022 (-4.21 ME as of June 30, 2021).
In the 3rd quarter, the group grew by 27% in the Safe Orthopedics scope and 5% in the Safe Medical scope. The turnover is 1.39 ME in the 3rd quarter. It brings to 4.24 ME the turnover over 9 months.
Cash position
As of June 30, 2022, the audited group cash flow amounted to 0.2 ME (3.9 ME at the end of June 2021).
It is reminded that the maximum balance of the financing under the OCEANE Alpha Blue Ocean program still to be received amounts to €2.4 million. The impact of the share issues linked to the conversion of the OCEANEs is such that a shareholder holding 1% of the company’s capital on the launch date of the program, December 9, 2021, is reduced to 0.11% over a diluted basis, after issuance of the various shares resulting from the conversion of the Oceane bonds.
©2022 Boursier.com